. Association of PD-L1 expression with PFS and OS in GCB and non-GCB subtype. (A) Association between PD-L1 expression in tumor cells and PFS in GCB subtype. (B) Association between PD-L1 expression in tumor cells and OS in GCB subtype. (C) Association between PD-L1 expression in the TME and PFS in GCB subtype. (D) Association between PD-L1 expression in the TME and OS in GCB subtype. (E) Association between PD-L1 expression in tumor cells and PFS in non-GCB subtype. (F) Association between PD-L1 expression in tumor cells and OS in non-GCB subtype. (G) Association between PD-L1 expression in the TME and PFS in non-GCB subtype. (H) Association between PD-L1 expression in the TME and OS in non-GCB subtype. PFS, progression free survival; OS, overall survival; GCB, germinal center B cell-like; TME, tumor microenvironment; PD-L1, programmed cell death ligand-1.
. Association of PD-L1 expression with PFS and OS in BCL-2 expression subtype. (A) Association between PD-L1 expression in tumor cells and PFS in BCL-2 score of 2-3. (B) Association between PD-L1 expression in tumor cells and OS in BCL-2 score of 2-3. (C) Association between PD-L1 expression in the TME and PFS in BCL-2 score of 2-3. (D) Association between PD-L1 expression in the TME and OS in BCL-2 score of 2-3. (E) Association between PD-L1 expression in tumor cells and PFS in BCL-2 score of 0-1. (F) Association between PD-L1 expression in tumor cells and OS in BCL-2 score of 0-1. (G) Association between PD-L1 expression in the TME and PFS in BCL-2 score of 0-1. (H) Association between PD-L1 expression in the TME and OS in BCL-2 score of 0-1. PFS, progression free survival; OS, overall survival; BCL, B cell leukemia 2; TME, tumor microenvironment; PD-L1, programmed cell death ligand-1.
